Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
Market closed$15.00$0.00 (0.00%)After hours $15.00 · 0.00%
Key statistics
Previous close$15.00
Open$15.20
Day high$15.20
Day low$15.00
52-week high$16.30
52-week low$14.34
Market cap3.39B
Volume150.00
Average volume2.00
P/E ratio15.11
Forward P/E—
EPS0.99
Dividend yield+1.86%
Market context
Why it moved
RPHCF showed no significant price movement today, trading flat with minimal volume, as no relevant company-specific news or market catalysts were identified to drive any directional change.
What is happening
Recent company-specific developments and publisher coverage.
SeeNews · July 9, 2026Rohto buys majority stake in Serbian cosmetics distributor Magic CodVisionMonday.com · June 5, 2026Luminopia Announces First International Licensing Agreement With ROHTO Pharmaceutical to Launch Pediatric Amblyopia Treatment in JapanPR Newswire · June 2, 2026Luminopia Announces First International Licensing Agreement with ROHTO Pharmaceutical to Launch Pediatric Amblyopia Treatment in JapanBusiness Wire · May 7, 2026Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with ShareholdersThe Armchair Trader · May 5, 2026Activist turns up the heat on Rohto PharmaceuticalBloomberg.com · April 30, 2026UK Fund AVI Wants Chairman of Japan Drugmaker Rohto to LeaveMicrosoft · November 13, 2025Rohto Pharmaceutical builds a global ERP platform with Dynamics 365 Mt Newswire · June 5, 2026Daiwa Securities Upgrades Rohto Pharmaceutical to Outperform from Neutral; Price Target is 2,880 Yen Mt Newswire · December 22, 2025Jefferies Upgrades Rohto Pharmaceutical to Buy From Hold, Adjusts Price Target to 2,980 Yen From 2,200 Yen Mt Newswire · December 3, 2025Jefferies Upgrades Rohto Pharmaceutical to Hold From Underperform, Adjusts Price Target to 2,200 Yen From 2,000 Yen